New drug advancements presented at ASCO
21 Jul 2017
New drug advancements presented at ASCO
iManageCancer: Psycho-emotional and family resilience monitoring
Celebrating a 10 year partnership: ecancer and the IEO
New drugs on the horizon for pancreatic cancer
Recommendations for surveillance of adenomas
Neo-adjuvant/adjuvant treatment in gastric cancer
New evolutions for the neoadjuvant and adjuvant treatment of oesophageal cancer
Do variations in prognostic risk stratification criteria for patients with gastrointestinal stromal tumours affect adjuvant treatment?
Implementation of a wait and see program for rectal cancer
Cholangiocarcinoma and gallbladder cancer
Left versus right in colon cancer
The GI oncologist of the future